The US District Court for the Middle District of Tennessee recently granted BioMimetic Therapeutics Inc.’s motion to dismiss the class action against it, and denied plaintiffs leave to amend their complaint. Shareholders...more
- BioMimetic Therapeutics Class Action Clinical Trials Deficiency Notices Duty to Disclose Life Sciences Securities Exchange Act Shareholder Litigation Shareholders
JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...
Learn More or Schedule a demo